The QualityStocks Daily Blog
Covering Micro-Cap and Small-Cap Companies

Our writers and journalists keep investors up to date with the latest news from around the markets. The QualityStocks Blog is another extension of our commitment to help the investment community discover emerging companies that offer excellent growth potential.

The Value Drivers of InMed Pharmaceuticals Inc. (IMLFF)

April 11, 2017

The cannabis plant is comprised of, among other things, phytochemicals that have evolved over time to become very biologically active. Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids. To date, over 90 cannabinoids have been isolated from cannabis, each affecting the body’s cannabinoid receptors and responsible for distinctive pharmacological effects. The cannabinoids that bind more selectively to certain receptors have become more desirable for medical usage because of the advantage offered. Examples of phytochemicals that have been developed into pharmaceutical drugs include the bronchodilator (asthma), salicin (aspirin) and a number of cardiovascular agents.

InMed Pharmaceuticals is a Canadian drug discovery and development company with a unique focus on this area of cannabinoid science and the curative capabilities of cannabinoids. Since the 1980s, InMed has been developing a robust pipeline of therapies and products by leveraging its primary value drivers: its leadership team and its research and development into the extensive pharmacology of cannabinoids; its proprietary drug discovery platform; its proprietary cannabinoid manufacturing system; and its inventive drug delivery systems.

InMed benefits from the leadership of tested experts like Dr. Ado Muhammed, the company’s Chief Medical Officer. A proven leader in the field of cannabinoid therapies, Muhammed previously served as Associate Medical Director at GW Pharmaceuticals, a $3 billion cannabis biotechnology company. There, he played a strategic role in the delivery of core clinical research and key decision-making regarding R&D and product commercialization. Moreover, he was instrumental in leading that company through the development and regulatory approval of one of the first cannabis drugs in existence. InMed prides itself on being the only cannabis biotech company with a former GW Pharmaceuticals executive on board. This is a significant occurrence, as GW Pharmaceuticals is viewed as “the cannabis industry leader,” as well as a long-term biotech investment with a promising future. Since 2013, GW Pharmaceuticals’ shares have shot up from less than $9 to over $121 as of March 30, 2017, bringing it to a market value of approximately $2.9 billion.

Bioinformatics assessment is another of InMed’s core value drivers. As a general approach, this type of assessment opens up the world for future drug discovery, as it combines scores of data sets and builds holistic models to approach a specific disease. As part of its operations, InMed has created a computer-based program that assists in the discovery of novel cannabinoids using: (a) far-reaching algorithms to integrate data from various bioinformatics databases, (b) a database on the structure of currently-approved pharmaceutical products, and (c) a broad database containing the 90-plus individual cannabinoid drugs that have been found in cannabis. The company is now using this bioinformatics assessment tool to classify bioactive compounds within the cannabis plant that have the potential to have physiological impacts on specific diseases and to, ultimately, identify new drug candidates that heighten the therapeutic benefits of cannabis while restricting its adverse effects.

Biosynthesis — a process used in industrial applications, including the use of bacteria- or yeast-based systems for the production of pharmaceuticals — is also one of InMed’s primary value drivers. InMed is currently building up a high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. This process integrates the inbuilt safety and known effectiveness of natural drug structures with the convenience, control and quality of a laboratory-based manufacturing process. InMed’s proprietary approach to the production of pharmaceutical grade, bio-identical cannabinoids is a disruptive technology in the current and rapidly-emerging cannabinoid pharmaceutical sector.

Along with its proprietary in silico drug/disease bioinformatics assessment tool and its cannabinoid biosynthesis technology, InMed’s drug development pipeline is also a core asset. The company is leveraging a conservative clinical budget and accelerated drug development timelines to target unmet medical conditions using its disease-specific formulations. Presently, the company has two drug candidates in its pipeline:

  • INM-750 is under pre-clinical development for the treatment of epidermolysis bullosa, an orphan pediatric disease that is typified by extremely fragile skin. Epidermolysis bullosa has no current approved therapies and represents an estimated $1 billion market.
  • INM-085 is under pre-clinical development for the treatment of glaucoma, a severe eye disease with a global market of approximately $5.6 billion.

InMed Pharmaceuticals is also seeking and developing novel drug candidates for the treatment of conditions relating to dermatology, pain and inflammation, metabolic and respiratory diseases, and the ocular region and central nervous system.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

Grey Cloak Tech, Inc. (OTC: GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic.

ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more effectively drive sales and attract new customers.

The innovative solutions offered by ShareRails enable local retailers to capture the millions of online shopping searches they are currently missing out on because their product inventories and other key information is not currently available online and, therefore, does not appear in relevant searches and cannot be viewed digitally.

Most of today’s retail sales are Web-influenced. By utilizing digital marketing channels, merchants can enhance the in-store shopping experience for customers and simultaneously boost sales. The ShareRails O2O platform enables retailers to put their product catalogs online, along with product location and availability, and make the information searchable. The platform also offers digital merchandising tools that include an outfit builder and wishlist app along with conversational shopping tools. Through ShareRails O2O, merchants can additionally tap into data that details shopper insights and behavioral trends. Add-on services include click-n-collect, reservations for in-store pickup, and local delivery.

ShareRails additionally offers Dress.li, which is a recommendation and reward platform that connects shoppers to stylists, bloggers and other fashion influencers who provide them with expert shopping advice and uniquely styled looks and, simultaneously, connects the consumers to fashion retailers. Through Dress.li, the challenge of creating a seamless social shopping experience has finally been mastered! This platform facilitates live shopping communications, curation and content creation and lets users join a global network of trendsetters. Through this network, users can inspire and be inspired, accessing and sharing product recommendations and unique looks and receiving rewards each time another user makes a purchase from their recommendations. This platform not only provides an enjoyable and exciting network for shoppers and fashionistas, but it simultaneously supplies retailers with a lucrative outlet for acquiring new customers through a built-in global sales force of fashion influencers. As these Dress.li stylists create and share looks, they also deliver pre-qualified sales leads and conversions and are rewarded for doing so.

Joined together, Grey Cloak Tech’s industry-leading click-fraud detection solutions and the exciting retail-boosting products delivered through ShareRails offer a broad package of services to both protect businesses in the digital world and help them utilize digital channels to bolster their sales and enhance customer engagement.

Grey Cloak Tech continues to serve as an industry leader in developing the most effective and comprehensive weapons to fight online security threats. The company is keenly focused on protecting its clients’ interests through the identification of fraud patterns at the very earliest stages. When businesses partner with Grey Cloak Tech, they can look forward to benefiting from industry-leading technology, a top-tier client services team, and an augmented bottom line.

For more information, visit the company’s website at www.GreyCloakTech.com

Let us hear your thoughts: Grey Cloak Tech, Inc. Message Board

CD International Enterprises, Inc. (CDII) Announces Engagement of QualityStocks Corporate Communications Suite

April 10, 2017

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, today announced that it has engaged the Corporate Communications Services of QualityStocks.

“As a growing international brand, we want to maintain communication with our shareholders while increasing our online visibility and attracting new investors,” Dr. James Wang, chairman and CEO of CD International, stated in a news release. “We are excited to work with QualityStocks to achieve these communication goals and look forward to utilizing their expertise in this area.”

Under the agreement, QualityStocks will leverage its network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to relay CD International’s corporate message and progress to the investment community.

“CD International is rapidly expanding its reach in China and the Americas, and most recently announced its plans to distribute cannabidiol (CBD) extract in the United States,” noted the QualityStocks Team. “Our goal is to provide the investment community with an accurate picture of how the company is growing its existing business, while working to capture its share of this new market.”

For more than 11 years, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value.

For more information, visit the company’s website at www.CDII.net

Let us hear your thoughts: CD International Enterprises, Inc. Message Board

InMed Pharmaceuticals, Inc. (IMLFF) Offers More than Just a Non-THC Cannabinoid Drug Pipeline

Now that 28 states have passed comprehensive medical marijuana laws, conditions have never looked better for expanding research and development (R&D) into the therapeutic benefits of cannabinoids, which is exactly what InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is doing. Its efforts have already borne results: the company has two novel drug candidates in its pipeline. But there’s more to InMed than meets the eye; the Vancouver, Canada-based company has developed a proprietary process to manufacture cannabinoids based on biosynthesis. In addition, it has constructed an algorithm to identify the cannabinoids most likely to have beneficial therapeutic effect. With this triad of core assets, InMed looks poised to join the ranks of Big Pharma.

Of the 480 or so substances found in the cannabis sativa plant, about 60 are unique to the plant and are called cannabinoids. Perhaps the best known of these is delta-9-tetrahydrocannabinol (THC), which is responsible for the ‘high’ derived from marijuana, but cannabinol (CBN) and cannabinodiol (CBDL) will also get you stoned. Most other cannabinoids are not psychoactive and cannabidiol (CBD), the one which occurs the most in the plant (about 40 percent of cannabis resin), actually mitigates the psychoactive effects of THC.

CBD is also known to dispel anxiety, which, according to the Anxiety and Depression Association of America (http://dtn.fm/LUjx9), is the most common mental illness in the U.S., afflicting 40 million Americans. Cannabinoid R&D has the potential not only to ease their suffering but the burden of those who suffer from a variety of other ailments.

At InMed, R&D has led to the development of a proprietary process to manufacture cannabinoids. Traditionally, cannabinoid compounds have been isolated by processing and purifying cannabis resin from actual plants. Alternatively, synthetic cannabinoids are created in the lab in a costly, time-consuming process that, in the end, may not produce a substance quite like nature’s. The InMed approach is to apply cannabinoid DNA to E-coli bacteria. The E-coli DNA is then removed leaving just the cannabinoid DNA, which can then replicate, in a process known as biosynthesis.

Although novel as a means of developing cannabinoids, biosynthesis is widely employed in the pharmaceutical industry. For example, the insulin used by millions of diabetics worldwide on a daily basis is manufactured through biosynthesis.

InMed has also created a bioinformatics program that assists in the identification of novel cannabinoids to treat diseases based on the current non-cannabinoid drugs being used. The program uses comprehensive algorithms to integrate data from numerous bioinformatics databases, including a database on the structure of currently approved pharmaceutical products, and an extensive database on over 90 individual cannabinoid drugs found in cannabis.

Using its own proprietary analytics program and manufacturing methodology, InMed has advanced two drug candidates along its pipeline. The first, INM-750, is for the treatment of a rare genetic connective tissue disorder, called epidermolysis bullosa (EB), that affects roughly one out of every 20,000 births in the United States. The condition, which currently has no approved treatment or cure, has been called “The Worst Disease You’ve Never Heard Of” by the Dystrophic Epidermolysis Bullosa Research Association of America. INM-750 works by replacing missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

Also in pre-clinical trials is INM-085 for the treatment of glaucoma, a leading cause of blindness, according to the Glaucoma Research Foundation. The drug reduces the elevated intra-ocular pressure that is often associated with glaucoma. It is targeting a large market. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and that the disease has blinded more than 120,000.

InMed continues to expand its cannabinoid R&D. This has already produced huge success for GW Pharmaceuticals (market cap: $3 billion) after its Sativex, derived from cannabis, was approved for the treatment of multiple sclerosis (MS).

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

Player’s Network, Inc. (PNTV) – Using Unique Business Models to Increase Revenue

April 7, 2017

Player’s Network, Inc. (OTCQB: PNTV) is a fully reporting diversified holdings company, operating in two main industries: medical marijuana and media. The company’s primary objective is to create shareholder value by identifying opportunities in niche emerging markets. PNTV has three prominent subsidiaries: Next Gen TV, WeedTV.com, and Green Leaf Farms, all of which operate under profitable business models.

The primary goal for WeedTV.com is to generate revenues from its proprietary channels and clients. Proprietary channels that Player’s Network is able to generate revenues through include membership subscriptions, advertising, and cross-selling with other organizations. In addition to this, the company’s Next Gen TV gives businesses, brands, and celebrities the tools to create their own network, allowing them to build channels that can be viewed from anywhere.

Player’s Network also owns 86% of Green Leaf Farms Holdings, LLC, better known as Green Leaf. To generate revenue, the company has identified the “best breed” operators to ensure the highest quality of medical marijuana and edibles. These are then legally sold to dispensaries across the state of Nevada. The company is projecting significant revenues, especially for Green Leaf Farms due to recreational marijuana being passed in Nevada.

WeedTV.com, a social media network and informational tool for the marijuana industry, and Green Leaf operate under a unique business model compared to their competitors. Because both are partially or fully owned by Player’s Network, the company combined its knowledge of production, distribution, and marketing, creating a strategy whereby WeedTV.com is able to push Green Leaf products while promoting other companies, leading to two sources of revenue.

Green Leaf is a private company with a Medical Marijuana Establishment license that has 3.4 acres of cultivation and production facilities. In order to maintain high levels of production with its current level of promotion and distribution, Player’s Network aims to continue developing and launching platforms such as WeedTV.com in order to continue expanding its products and services to customers.

For more information, visit the company’s website at www.PlayersNetwork.com

Let us hear your thoughts: Player’s Network, Inc. Message Board

Marina Biotech, Inc. (MRNA) Sets Further Development of Drug Candidates IT-102 and IT-103, Signs Windlas Healthcare Manufacturing Agreement

Marina Biotech Inc. (OTCQB: MRNA) filed a 10K with the SEC on April 5, 2017, for its year ended December 31, 2016. The late stage biopharmaceutical company summarized its achievements in 2016 and provided an outlook into its 2017 performance, including its planned clinical trials in 2018. Marina Biotech specializes in creating and commercializing innovative therapies for treatments of cancer, hypertension, and arthritis.

The firm plans to move by the first quarter of 2018 into a phase 3 clinical study of its drug candidate, IT-102, a fixed dose combination (FDC) bi-layer tablet, said Joseph Ramelli, chief executive officer of Marina Biotech. It recently signed an agreement for Windlas Healthcare Limited to manufacture the tablet, positioning Marina Biotech for the Phase 3 study. That India-based firm has facilities that are approved by the Food & Drug Administration (FDA) in the U.S., as well as the European Union Good Manufacturing Practices (EU cGMP).

The company also reported:

  • Marina Biotech expanded its unsecured credit line from its chairman, Dr. Vuong Trieu, on April 4, 2017, for an additional $500,000. The initial line was for $540,000 secured last November. The company had drawn down $250,000 of that by December 31, 2016. The company also secured another line of credit from Autotelic, Inc., for the commercialization of IT-102 and IT-103.
  • The company announced that it has completed its merger with IThena Pharma, enabling it to advance its development of combination tablets for arthritis, pain, cancer and hypertension. The transaction with IThena Pharma has put in motion a new pipeline by Marina Biotech that advances its development of combination therapies.
  • Marina Biotech announced the results of new preclinical and clinical data for its drug candidates IT-102 and IT-103. These results support the further development of both for the treatment of hypertension/pain, Ramelli said. Among these results was the indication that IT-102 and IT-103 could serve as unique anticancer agents.
  • In February of 2017 the company entered into a licensing agreement with LipoMedics, under which Marina Biotech could receive up to $90 million in milestone payments which are success based. Under that agreement, Marina Biotech gave a license to LipoMedics for its SMARTICLES platform for the delivery of nanoparticles, including small molecules.

For more information, visit www.MarinaBio.com

India Globalization Capital, Inc. (NYSE: IGC) at the Forefront of Innovation Thanks to Strategic Alliances

How does a company in the mining industry successfully move toward becoming a leader in the marijuana sector, specifically cannabinoid-based pharmaceutical therapies that treat a variety of diseases and conditions? In the case of India Globalization Capital, Inc. (NYSE MKT: IGC), the answer is creative management’s ability to identify opportunity, coupled with a relentless drive toward innovation.

IGC made its switch to the marijuana industry after its CEO, Executive Chairman, and President Ram Mukunda was unafraid to recognize and act on a need for the company to make a positive and swift switch to a stronger and more lucrative market. This led IGC to cannabis and, in particular, phytocannabinoids.

The cannabis plant has a number of subspecies, some of which have psychoactive properties and others do not. Cannabis sativa is psychoactive, while other forms, such as Cannabis Sativa L., or hemp, and Cannabis ruderalis, are not. In fact, the latter offer high levels of cannabidiol, which is most commonly used on a medical level.

Legal marijuana is now becoming one of the fastest growing industries in the United States, expected to create just under 300,000 jobs for Americans by 2020 (http://dtn.fm/fEq5E), and an increasing number of states are legalizing the drug both medically and recreationally, with the potential for further legalization on the horizon.

Although the marijuana industry is growing at an exponential rate, federal laws that classify marijuana as a Schedule 1 drug make it hard for businesses to reach their full potential,but IGC has been able to research and take advantage of cannabinoids, since these are not illegal. Part of IGC’s success is due to the fact that the company is not going about its mission to help patients suffering from pain, PTSD, seizures, and many other diseases on its own. The company is creating strategic alliances with doctors, researchers, dispensaries, and practitioners, among other industry experts, in order to develop a product portfolio of much needed phytocannabinoid-based therapies.

IGC has entered into the industry aware that there is a huge amount of information already available at the grassroots level of the marijuana industry. This is why it is seeking IP transfers with producers who know about growing hybrids and strains that are rich in specific phytocannabinoids that can be used in a pharmaceutical environment to help patients who could benefit from cannabinoids.

In addition to its extensive development pipeline, which includes six products for various disorders in both adults and animals and three expected to go through to preclinical trials this year, IGC is planning on taking equity positions within companies that are directly and indirectly part of the marijuana industry, another way that investors can take advantage of a booming industry.

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

InMed Pharmaceuticals, Inc. (IMLFF) Adds to Its Drug Development Pipeline

April 6, 2017

A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline. An expedited drug development timeline is now in place for INM-750 for epidermolysis bullosa (EB), with a potential market of about $1 billion. The disease is characterized by fragile skin in children. The company has also announced the development of INM-085 for glaucoma, which represents a potential global market of over $5 billion.

Resulting in a defect in the connective tissue between the dermis and epidermis, most often caused by a lack of keratins, EB currently has no medication-based treatments. Multiple cannabinoids are the active ingredients of INM-750, which is now under development as a topical drug. These were selected to manage keratin levels in people with EB, in which fragile skin can blister and tear easily with the slightest friction or trauma. The cannabinoids were also chosen to address inflammation, itching, wound healing, pain, and skin regeneration.

One of the leading causes of blindness, glaucoma is associated with high fluid pressure in the eye, which can damage the optic nerve. The first glaucoma treatment of its kind, INM-085 will be a multi-target, multi-mechanism therapy. It will contain multiple cannabinoids that can reduce elevated intra-ocular pressure and protect retinal ganglion cells and optic nerve tissues. The drug will be designed to be applied directly to the eye as a topical formulation.

The new drugs in development are in addition to the company’s other initiatives, including a number of cannabinoid-based drugs. Dr. Ado Muhammed, MD, DPM, MFPM, chief medical officer of IMLFF, is a leader in developing cannabinoid therapies. Prior to joining InMed, he served as executive on board at GW Pharmaceuticals (NASDAQ: GWPH), where he was involved in the development and regulatory approval of one of the first prescription cannabis-based drugs on the market. Muhammed has had strategic roles in the research and development, clinical development, and commercialization of specialty drugs.

InMed’s core assets also include a computer-based drug/disease target screening tool and a proprietary cannabinoid manufacturing system. The bioinformatics tool has helped InMed identify novel cannabinoids thanks to algorithms that have allowed the integration of data from various bioinformatics databases. It also uses a database of approved pharmaceutical products and one consisting of over 90 cannabinoid drugs. The company has used the tool to associate approved pharmaceuticals with cannabinoids that have similar structures in order to identify which ones will act on specific genes and proteins.

A biosynthesis system is in development, which is based on similar processes that use bacteria and yeast in industrial applications. It will allow InMed to manufacture naturally occurring cannabinoids in the laboratory at high yields. An alternative to chemical manufacturing methods, it could address production, quality control, purification, and structural integrity. The system is expected to be a revolution in the rapidly emerging cannabinoid pharmaceutical sector.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

SinglePoint, Inc. (SING) Set to Capitalize on Congressional Push to Regulate and Tax Marijuana

The U.S. Congress in March introduced legislation to regulate and tax marijuana and to remove it from the federal Controlled Substances Act. The move (http://dtn.fm/w96Hp) would effectively end cannabis prohibition and allow it to be regulated in a way alcohol has been since 1933. This move would be highly beneficial for SinglePoint, Inc. (OTC: SING), a leading mobile technology and payment solutions company that provides ancillary services to the marijuana industry.

Legislation was introduced by Sen. Ron Wyden (D-OR) and Rep. Jared Polis (D-CO). It would allow the states to choose to legalize cannabis at their discretion. Also, federal regulations could be imposed on cannabis businesses, even in those states where marijuana is legal. A federal excise tax on cannabis products would be put into effect by a Senate bill (introduced by Rep. Earl Blumenauer (D-OR)), and the House is also considering such a measure. These measures reflect the stance that the administration of President Donald Trump has taken on the legalization of marijuana.

Greg Lambrecht, CEO of SinglePoint, recently noted, “The Trump administration has voiced its intention to empower the states in regards to legalizing medical marijuana. President Donald Trump himself has stated that he believes medical marijuana can help people. At this time, we believe the administration will stay true to their position of empowering the states to make the right call. There are many medical shops here in Phoenix. So far, none of them have said they are being negatively impacted by the current administration or the policies it says are in the works.”

Additional bills address cannabis legalization on a criminal justice front. Changes to cannabis policy could include a reduction of cannabis penalties and an elimination of many legal repercussions now associated with federal convictions. Rep. Blumenauer has expressed concern that individuals could be trapped between federal and state laws and that changes are needed to ensure fairness.

Public support for legal cannabis has grown from 52% of adults in 2014, to 57% in 2016, according to a General Social Survey. The new numbers are supported by a recent Quinnipiac University poll as well. Still, some states, such as California, fear there may be a federal crackdown. Some have said federal intervention could restore prohibition where cannabis is legal, which could spawn a new era of chaos due to an unregulated underground market and criminal justice issues.

SinglePoint has seen much revenue potential in the realm of legal cannabis, and hopes measures will be taken to streamline federal and state oversight of the market. Its interests go beyond investing. The congressional push should also help boost the value of its SingleSeed (www.SingleSeed.com) payments solutions for businesses in the cannabis industry. “For the near term, the best way the administration can help would be to issue guidelines on how the cannabis business can be successfully banked,” Lambrecht added.

Recently, SinglePoint announced the acquisitions of Convectium, a manufacturer and distributor of cannabis-related equipment and packaging solutions. The projections of $3.5 million in sales for 2017, according to a March press release (http://dtn.fm/A5y0U), are attractive to SinglePoint investors who have seen opportunities to diversify the company’s revenue streams. At the start of 2017, 28 states had legalized marijuana in some capacity.

To stay tuned for more details about new cannabis legislation, and to learn more about SinglePoint and its acquisitions in the industry, go to www.SinglePoint.com.

Let us hear your thoughts: Singlepoint, Inc. Message Board

ChineseInvestors.com, Inc. (CIIX) Combating Alzheimer’s Disease through Development of CBD Health Products

April 5, 2017

China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy. Unfortunately, China’s longer-lived population has resulted in a significant increase in the number of people having to care for seniors with various mental dysfunctions, most notably dementia and, in particular, Alzheimer’s disease.

Alzheimer’s is a neurodegenerative type of dementia that is most prominent in elderly people. The disease is a disorder that involves the death of brain cells leading to various cases of memory loss and cognitive decline. The disease starts mildly but eventually progresses to the point that patients affected often cannot recognize familiar surroundings and eventually lose almost all of their short term memory capabilities.

Recent statistics show that over 1,300 people aged 60 or over get lost or go missing every day in China (http://dtn.fm/zd6uW). Dementia of various forms was said to be the main cause of these disappearances. More than 70% of the elderly people who go missing have memory problems, with 25% of these having Alzheimer’s disease.

Alzheimer’s cases now makes up more than 60% of all dementia patients in China, and, because people are living longer, the number of people affected by the disease is growing rapidly. ChineseInvestors.com, Inc. (OTCQB: CIIX), a company focused on sharing real-time market analysis to Chinese-speaking investors and which also has the aim of becoming the premier producer of cannabidiol (CBD) oil to mainland China, is hoping to help manage this growing problem.

Recent studies show that Alzheimer’s is a disease that affects the whole nervous system (http://dtn.fm/3uyJX), not just the brain. This means that strengthening the endocannabinoid system is extremely important to managing symptoms of Alzheimer’s, something of which CIIX is very aware. From various research, the company has found that CBD oil can be effective in restoring memory, and it plans to further study the efficacy of CBD oil for the treatment of Alzheimer’s disease.

In addition to the launch of ChineseCBDoil.com, the world’s first online CBD health products store in Chinese, and its cannabis mobile application, ChineseInvestors.com will be investing in CBD drug R&D enterprises with the aim of developing a range of CBD-based drugs that can help mitigate the suffering of patients with Alzheimer’s, among other diseases.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

eXp World Holdings, Inc. (EXPI) Projects Agent/Broker Count Will Rise To 5,500-6,500 By Year End 2017

In its recent presentation at the MicroCap Conference in New York, eXp World Holdings, Inc. (OTCQB: EXPI) projected that its count of agents/brokers would be in the range of 5,500-6,500 by the end of this year, according to Glenn Sanford, CEO and company founder. eXp World Holdings is the holding company for eXp Realty LLC and eXp Realty of Canada, Inc. Through these subsidiaries, EXPI operates as a unique 24/7 cloud-based brokerage company that enables agents to earn company stock through production and offers them a percentage of gross commissions earned by other agents they attract into the company. eXp World Holdings finished its year ended December 31, 2016, with 2,401 agents/brokers, and, by March 15, 2017, that number had grown to more than 3,000. The company operates in 43 U.S. states, the District of Columbia, and Alberta, Canada.

Sanford said that EXPI’s count of agents/brokers is mushrooming due to several factors. The firm offers stock incentives to agents/brokers and a share of commissions earned by new agents they attract to the company. It also offers low costs versus traditional brick-and-mortar models and immersive 3D cloud campuses for more effective and available training and communication. It represents a significant change from the traditional real estate office model, he told conference attendees, indicating that a high-tech “perfect storm” helped inspire the inception of this different approach to the realty brokerage based on a cloud platform.

Traditionally, the broker/owner or manager of a real estate office is responsible for the growth of agent count, he explained. In EXPI’s model, all agents are actively involved in recruiting others to join. Attractive features to new agents include lower costs, high technology training, stock options, and a cloud-based campus. Two of the Wall Street Journal’s Top 50 real estate agents have now joined the company, he said.

Sanford told conference attendees that the firm’s agents tend to be younger, closer to 40 years of age, as opposed to the typical agent of about 54. He said its three-year vesting program is attractive to new agents, as are the prospects of earning options on company stock and receiving a percentage of commissions earned by company agents they recruit. The three-year vesting is an important tool to retain agents, he said. It serves as an incentive to stay. He also noted that the average commission earned on a sale is a healthy $9,000.

He added that there remains plenty of room for growth for the company, saying that its largest market is currently Texas, where it has more than 800 agents — almost one third of the company. By comparison, in the New York/Connecticut market, he said, the firm has little presence today and only a handful of agents.

For future growth as the company expands, Sanford noted that EXPI is investing in eight or nine developers who are working on a new back-end platform for the company. Sanford said that, because it is cloud-based, the company can quickly grow into any market without the traditional costs of brick-and-mortar.

For more information, visit the company’s website at www.eXpWorldHoldings.com

Let us hear your thoughts: eXp World Holdings, Inc. Message Board

India Globalization Capital, Inc. (NYSE: IGC) From Mining to Marijuana

March 31, 2017

At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease? The enigma can be disrobed by looking at the tenacity and vision of its management.

Ram Mukunda has served as Executive Chairman, CEO and President of India Global since inception in 2005. He holds distinguished mathematics and engineering degrees and worked in multiple Wall Street positions for more than 25 years, serving communications firms such as Intelsat SA and Startec. Mukunda actually founded Startec in 1991 to provide VOIP service to emerging economies. As Chairman and CEO of Startec, he led the company to a $60 million public stock offering in 1997. His introduction to the mining industry came a few years later through a company he co-founded, India Globalization Capital. The company mined and converted low-grade iron ore to high-grade ore. Iron ore prices subsequently plummeted nearly 75 percent, putting it below the cost of production. That’s when Mukunda made a difficult decision and charted a course change for the company.

Realizing that the lucrative mining business was bust, he searched for a growth arena to position the company and move forward. He ultimately centered on the burgeoning cannabis industry and the myriad of potential medical benefits. Mukunda and his team realized that there were a lot of untapped uses for cannabinoids and cannabis-based extracts. They recruited a team of highly skilled doctors and patent attorneys, comparing anecdotal stories with scientific evidence and identifying areas where patents had not been filed. This process has yielded results.

The company now has a pipeline of patent pending cannabinoid-based drugs targeting large market maladies, which includes therapeutics for neuropathic pain, human and animal seizures, refractory epilepsy and eating disorders. Several of these therapeutic drugs are scheduled for pre-clinical trials this year. The company is transitioning fast from building research teams and developing a patent portfolio to marketable products.

For the past few years, India Globalization Capital has also focused interest on cannabis-based combination therapies, using cannabis-based extracts in combination with other medications to reduce side effects and increase bioavailability and absorption. As one of the first to enter this space, the company has been building intellectual property around these precepts and expects to reap substantial rewards from this arena.

From mining to medical marijuana would seem an incredible leap, but, when looking at India Global and the leadership of Ram Mukunda, it would be tough to bet against a leader with such tenacity and vision. And with a $12MM market cap, IGC is quite compelling given the valuations attributed to its peers.

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

AzurRx BioPharma, Inc. (NASDAQ: AZRX) Overcoming Current Exocrine Pancreatic Insufficiency Treatment Limitations

Exocrine Pancreatic Insufficiency, or EPI, is a problem in a person’s digestive system. Simply put, EPI is when the pancreas cannot produce enough of the enzymes that the body requires to break down and absorb nutrients. Unfortunately, this means that the body is unable to absorb the right fats and nutrients, often leading to weight loss.

There are a number of causes for EPI, such as inflammation of the pancreas; effects from surgery on the pancreas, intestines, or stomach; or even an inherited disease such as cystic fibrosis, Shwachman-Diamond syndrome, Crohn’s Disease, diabetes, or celiac disease. Symptoms do vary, but normally the patient will feel a pain or tenderness in the abdomen, problems with bowel movements, flatulence, and a feeling of being full.

Today, there has been a rise in the number of people with EPI, and this has been largely attributed to an increase in the number of patients diagnosed with diabetes and cystic fibrosis (CF). According to an article from PR Newswire (http://dtn.fm/uyF9L), there are approximately 70,000 people living with cystic fibrosis worldwide, with 1,000 new cases diagnosed each year. In addition, 50% of children with CF suffer from EPI from the moment they are born.

According to TransparencyMarketReserarch.com (http://dtn.fm/0tvSc), the EPI market is growing at an astronomical rate, and this is not expected to slow, since the number of patients diagnosed with diabetes is expected to grow to approximately 366 million by the end of 2030. PR Newswire reported an anticipated expansion of the market at a CAGR of over 8% between 2015 and 2023, allowing it to reach just under $3 billion.

Unfortunately, despite the expected market growth, current EPI treatments have a number of limitations. Aside from a healthy diet, the current treatment for EPI is Pancreatic Enzyme Replacement Therapy (PERT), but not only are these treatments not very effective, they also show a lack of stability in an acidic environment and carry a high pill burden, which can be highly inconvenient for patients.

Luckily, AzurRx BioPharma, Inc. (NASDAQ: AZRX), a development stage biopharmaceutical company focused on creating treatments for patients suffering from gastrointestinal diseases such as EPI, is currently in Phase IIa of the development of MS1819 lipase, a non-systemic, yeast-derived recombinant enzyme.

This orally-administered capsule is not only showing significant potential for the treatment of EPI in patients with chronic pancreatitis and cystic fibrosis; it is also demonstrating activity in long chain fats and stability in protease and bile salt environments. MS1819 lipase could give patients suffering from EPI the chance to reduce their pill burden from 25 to 40 pills a day to as little as five to eight.

For more information, visit the company’s website at www.AzurRx.com

National Waste Management Holdings, Inc. (NWMH) Decreasing Excessive Waste Materials by Recycling Compliant Construction and Demolition Materials

Construction and demolition (C&D) materials represent the debris from the demolition, construction, or renovation of buildings, bridges, or even roads. C&D materials are normally heavy materials such as concrete, wood, asphalt, gypsum, bricks, glass, some types of plastic, salvaged building components, metals and trees, among other materials.

In the United States, C&D materials constitute a large percentage of waste, much of which can be transformed into new productive products. According to a report entitled ‘Advancing Sustainable Materials Management: 2014 Fact Sheet’ (http://dtn.fm/HiA4r), over 500 million tons of C&D debris were generated in 2014, with concrete making up 70% of it, asphalt 14%, wood more than 7%, and other products making up approximately 9% between them.

All the materials outlined above can either be reduced, salvaged, recycled, or reused by simply preserving existing buildings rather than constructing new ones, designing new buildings that can be adapted to make them last longer, establishing construction methods that allow for the disassembly and reuse of materials, using different framing techniques, and reducing the various types of interior finishes.

In addition, steps are being taken by companies such as National Waste Management Holdings, Inc. (OTC: NWMH) to reduce the impact C&D has on the environment. NWMH is a solid waste management company located in Central Florida.

The company is focused on operating according to an eco-friendly business model that has been put in place to combat unnecessary waste in Florida and New York. To pursue its mission of being environmentally conscience with a focus on sustainability, NWMH is committed to inspecting all loads and sorting all the materials that arrive in its landfills in order to accept only those that are compliant with the C&D Department of Environmental Protection standards.

In addition to the company’s high level of compliance with the Department of Environmental Protection (DEP), National Waste Management plans on using its picking station to aid the state of Florida in its quest to meet its mandate for 75% recycling by the end of 2020. This incentive will give the company the ability to increase its rate of recyclables and sales of commodities.

For more information, visit the company’s website at www.nationalwastemgmt.com

Let us hear your thoughts: National Waste Management Holdings, Inc. Message Board

MGX Minerals (MGXMF) Set to Disrupt Industry with New PetroLithium™ Technology

When Harvard professor Clayton Christensen coined the term ‘disruptive innovation’, he had in mind technologies like the one being developed by MGX Minerals, Inc. (OTC: MGXMF) (CSE: XMG) (FRA: 1MG). This innovative company is poised to ignite a revolution in the energy sector with technology that extracts lithium from oil and gas wells. Its PetroLithium™ methodology separates valuable minerals from the salt water that typically accompanies crude oil, offering a novel way to extract lithium, an essential ingredient in the batteries of our laptops, mobile phones, and other electronic devices and, increasingly, our cars. As MGX refines its technology, it is quickly acquiring oil and gas properties, and operation of its initial Petrolithium™ borehole well is set to commence soon.

In an Emerging Theme Radar report (http://dtn.fm/ZW8b8), Goldman Sachs (GS) called lithium the ‘new gasoline’, saying its ‘unique properties make it a key enabler of the electric vehicle revolution’. Advances in battery technologies and a growing desire to avoid the hazards of fossil fuels signal a period of sustained growth for electric vehicles, which are forecast to rise from their present three percent of the automobile market to a penetration of 22 percent by 2025. Current demand for lithium runs to about 160,000 metric tons. According to GS, ‘a one-percent increase in battery electric vehicle penetration would increase lithium demand by 70,000 metric tons of lithium carbonate equivalent (LCE) annually (or roughly half of current global demand for lithium).’

Lithium carbonate occurs in the salt water (brine) that accompanies petroleum (crude oil) as it’s pumped to the surface. However, petroleum brine, like gas in the early oil industry, has been treated as a waste product, and it’s either injected deep underground or stored in giant tanks after it is separated from the oil. These traditional disposal methods have resulted in environmental damage: polluting potable water supplies and causing landslides.

The PetroLithium™ process, consequently, holds the promise of killing two birds with one stone: extracting a valuable resource from material that would go to waste while offering a safer way to dispose of that waste. Extracting lithium from petroleum brine is also faster and less costly than conventional methods, like solar evaporation and hard-rock mining. In a recovery process specifically designed for the highly mineralized brine associated with petroleum, lithium brine evaporation times are expected to fall to less than one day. Traditional solar evaporation techniques take up to 18 months.

In early March, MGX reported encouraging results for tests on its latest petrolithium methodology. The extraction process was able to concentrate lithium more than 20-fold while removing contaminants in a low-energy process. Solutions of 67 mg lithium per liter of petroleum brine were concentrated to 1,600 mg lithium per liter.

MGX has significantly expanded its Alberta petrolithium portfolio through the acquisition of additional metallic and industrial mineral permits covering over 133,000 hectares, and it has acquired an additional 301 mineral claims encompassing 6,020 acres within the Paradox basin of southeastern Utah. The new claims further increase the company’s Lisbon Valley land package to 23,780 acres. The Lisbon Valley oil and gas field is located approximately 40 miles southeast of Moab, Utah, in the salt anticline belt on the southwest edge of the Paradox Basin in San Juan County. Historic lithium brine content there has been reported as high as 730 parts per million of lithium.

Last week, MGX announced it had entered into a joint operating agreement with a private vendor to act as operator and acquire a 75 percent working interest in certain oil and gas leases located contiguous to the company’s Lisbon Valley petrolithium project. Preparations to permit the petrolithium #1 borehole well will commence upon closing of the agreement.

MGX is offering a win-win combo with its PetroLithium™ technology, which promises a faster, less expensive method of lithium extraction, while disposing of oil and gas production waste in an environmentally friendly way. The company is a diversified mining company engaged in the development of large-scale industrial mineral portfolios in western Canada and the United States. MGX operates lithium, magnesium and silicon projects throughout British Columbia and Alberta, as well as petrolithium exploration in Utah.

For more information, visit the company’s website at www.MGXMinerals.com

Let us hear your thoughts: MGX Minerals, Inc. Message Board

ProBility Media Corp.’s (PBYA) Acquisition of One Exam Prep LLC is Key to Growth

March 30, 2017

ProBility Media Corp.’s (OTCQB: PBYA) acquisition of One Exam Prep LLC, which was completed earlier this year, is key to its growth strategy. One Exam Prep is currently specializing in exam preparation and certification in the construction industry. It offers continuing education and certification online or in a classroom setting in 20 states, with the goal of operating in all 50 states. ProBility Media reported revenue at greater than $1 million for Q1 ended January 31, 2017.

Houston-based ProBility is an EdTech company serving 15 vertical categories in more than 60 skilled trades. It is positioned as an industrial training resource for individuals and small businesses. It offers training services as well as materials for education, advancement in careers, and testing. Virtual reality training, now operational for the crane business, will be expanded into other industries. The company said it is also beginning to investigate international expansion.

One Exam Prep, based in Coconut Creek, Florida, offers low cost yet effective exam prep courses in the construction industry. The company owns more than 70 domains related to contractor licensing and continuing education, according to One Exam’s Rob Estell, and it has created hundreds of courses offered either online or in traditional classroom settings in more than 20 states.

For the three months ended January 31, 2017, ProBility Media recorded revenues of $1,088,180, compared to $878,005 during the same period of the prior year. The recent three-month sales total represented the company’s third consecutive quarter of year-over-year revenue growth. The results of One Exam are included in the consolidated financial performance, subsequent to January 1, 2017.

ProBility Media entered into a multi-year consulting agreement with Rob Estell, the founder of One Exam, through December 31, 2020. It includes salary, an annual performance bonus based on One Exam’s revenues and profits, a signing payment, and a non-recourse secured convertible promissory note valued at $300,000.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

Singlepoint, Inc. (SING) Interview Reveals How the Cannabis Industry is Incorporating Technology

The legalization of cannabis across many states in the U.S. has opened doors to various innovators, leaving the tech world to rapidly adapt to this trending industry. There’s now a strong move by cannabis-oriented businesses to incorporate common technologies found in other industries, and such innovations are not just found in dispensaries. Improvements are being made on the technology surrounding the agricultural, marketing, production, and distribution channels in the marijuana market. Technology is also being used to solve challenging issues such as payment options.

Singlepoint, Inc. (OTC: SING), a publicly traded holding company, offers payment solutions to the cannabis industry through its SingleSeed subsidiary. The company offers noncash payment solutions to marijuana businesses that are legal, easy to use, and safer for both the companies using them and the customers purchasing products. However, it is not just through payment solutions that Singlepoint is sparking innovation in the cannabis technology market.

Recently, Singlepoint has made public its plan to undertake strategic acquisitions of companies that are in the cannabis industry but which do not in any way touch the plant itself. As the marijuana market in the U.S. continues to flourish, this strategy has started to unfold with SING’s acquisition of a stake in Convectium, a company that has created a unique machine that fills and packages vape cartridges and disposable vape pens at a rate of 100 per 30 seconds.

In a recent interview with Donald Baillargeon from MoneyTV (http://dtn.fm/OCAe3), Greg Lambrecht, CEO of Singlepoint, announced that the company has provided its initial round of funding to Convectium, where demand and sales have soared for this quarter compared to the same quarter of 2016. According to Lambrecht, the Convectium product is a perfect acquisition for Singlepoint, not only because of its in-demand capabilities, but because it does not require direct involvement with the plant and, therefore, does not break any state or federal regulations.

According to Lambrecht, Singlepoint has entered into an independent sales agreement with Convectium, whereby Singlepoint will be selling the machine in order to increase its revenues. He continued to emphasize the greatness of both Convectium and its product during the interview, highlighting the fact that comparative financial results of 2016 and 2017 will soon be released.

With the legal cannabis market projected to grow at a compound annual rate of 17%, according to Forbes (http://dtn.fm/UmNX8), Singlepoint aims to focus its attention on cannabis enterprises rather than cultivation, allowing it to aid investors in the cannabis market to diversify their portfolios through equipment providers and consumer product makers. Despite marijuana still being classified as a Schedule 1 drug, Singlepoint is making strides in the cannabis technology market and plans to continue to diversify its revenue streams within the industry.

For more information, visit the company’s website at www.Singlepoint.com

Let us hear your thoughts: Singlepoint, Inc. Message Board

CD International Enterprises, Inc. (CDII) Announces Multi-Year Cannabidiol Distribution Agreement Serving US Market

Before the opening bell, CD International Enterprises, Inc. (OTC: CDII), through its wholly-owned CDI Shanghai Management Company subsidiary, announced its entry into a multi-year distribution agreement with Zhangjianjie Shengshi Agricultural Development Company (“Shengshi”) relating to the distribution of high-grade cannabidiol (CBD) crystal in the United States. Per the agreement, Shengshi will be responsible for large-scale production of CBD, which it processes from industrial hemp grown in China. From this production, up to 100 kilograms per month, or 1,200 kilograms per year, will be provided to CD International for U.S. distribution, with CDII maintaining exclusive U.S. distribution rights for an initial period of 10 years.

“We are very excited to enter this brand new business to develop a new profit center,” Dr. James Wang, chairman and CEO of CD International, stated in this morning’s news release. “CBD supplements have become a hot spot in the health products market in the U.S. … If we are able to distribute 100 kilograms per month or 1,200 kilogram per year in the U.S., we would generate over $60 million in revenues according to the current market wholesale price. Management is confident that our new business could generate substantial profit opportunities for our shareholders for years to come.”

This morning’s announcement follows a January news release in which CD International announced its entry into a one-year consulting agreement with Shengshi. Through that agreement, CDII will be offering Shengshi a variety of consulting services ranging from business development and market promotion to more specialized consultations regarding garden design, landscaping and management of online retailing, among others. Wang originally alluded to CDII’s plans to “develop a distribution business of Cannabidiol (CBD) extract out of industrial hemp in both North and South Americas” in the January update.

Despite the ongoing legal battle related to both medicinal and recreational marijuana use within the United States, CBD has already been legalized in all 50 states. Lacking a significant concentration of tetrahydrocannabinol (THC), which is responsible for the psychotropic effects stemming from cannabis use, CBD has been shown effective in treating a variety of ailments, including epilepsy, Alzheimer’s disease and cirrhosis of the liver.

According to a recent report published by The Hemp Business Journal, CBD is currently one of the fastest-growing market categories in the U.S. hemp and legal cannabis industries, boasting a compound annual growth rate of roughly 59 percent. The CBD industry accounted for an estimated $202 million in consumer sales in 2015, and forecasts call for sales to reach $2.1 billion by 2020.

For more information, visit the company’s website at www.CDII.net

MeetMe, Inc. (NASDAQ: MEET) Closes on 9.2 Million Share Public Offering, Sees 2Q2017 Target on Acquisition of if(we)

March 29, 2017

MeetMe, Inc. (NASDAQ: MEET) has closed on its public offering of 9.2 million shares of common stock at $5 per share. This is inclusive of the full option by underwriters for 1.2 million additional shares of common stock. Net proceeds will be used by the company for general corporate purposes and to potentially fund MeetMe’s pending acquisition of “if(we)”, a San Francisco-based social and mobile technology company, as well as other future takeovers.

MeetMe is a social network for meeting new people in the U.S. Some 80% of its one million daily user traffic comes from mobile devices, such as iPhones, iPads, and Android devices. It is becoming a gathering place for mobile users, the company said. It generates revenue from advertising, subscriptions, and virtual currency.

Targeted to close in 2Q2017, the “if(we)” acquisition would be made for $60 million in cash, and that company is anticipated to generate at least $9 million of adjusted EBITDA and be accretive to earnings in the first 12 months after closing, MeetMe noted in a news release.

“if(we)” had revenues of $44 million in 2016 and is the operator of TAGGED and Hi5, branded apps which enable people to meet and chat with others. The site features 10.4 million mobile chats daily, and 18,000 mobile app users are added each day. “if(we)” is available in 100 countries and 15 languages.

MeetMe said in its corporate presentation on the acquisition (http://dtn.fm/J4gAA) that the transaction is expected to generate cross-promotional opportunities. It added that there is a less than 5% overlap in user bases, and the two companies together can lower technology costs by standardizing products. Also, by utilizing MeetMe’s best practices, the company expects a convergence of certain key metrics, such as daily chats.

Funding for the acquisition will come from MeetMe’s cash on hand, cash from operations, and a new $30 million loan from J.P. Morgan. The combined company could generate revenues of $150 million annually and an EBITDA of $50 million, per MeetMe’s presentation materials.

For more information, visit www.MeetMeCorp.com

ChineseInvestors.com, Inc. (CIIX) Executes a First to Market Milestone

A population of over 1.2 billion people is one heck of a target market, especially when insulated by language. ChineseInvestors.com (OTCQB: CIIX) has leveraged this demographic to market a broad range of products, services and information specifically for the Chinese speaking population. The company provides real-time market commentary, analysis, and education-related services in the Chinese language and offers several types of subscription-based services. Headquartered in Los Angeles with offices in New York City and Shanghai, the company also offers consultation services to private companies seeking to go public, as well as advertising and public relations services.

Seizing opportunity, this diverse multi-faceted company recently executed a first-to-market milestone by creating the world’s only Chinese language, cannabinoid-based therapeutic health products online store, www.ChineseCBDoil.com. To supply consistently high quality products, the company entered into a wholesale agreement with a well-known CBD oil health brand manufacturer in January.

Marijuana use in China is illegal, but there are no legal strictures on the sale or use of therapeutic cannabis-based oils. Cannabidiol (CBD) oil is considered to have a broad range of medical benefits and, unlike medical marijuana products, CBD oil is non-psychoactive with low THC and high CBD content. CBD has shown varying efficacy in treating epilepsy, Alzheimer’s disease and cirrhosis, as well as providing relief from anxiety and stress. CBD interacts with the body through the endocannabinoid system. The endocannabinoid system regulates the body’s homeostasis, or general state of balance, impacting such functions as mood, sleep, appetite, hormone regulation, pain and immune response. Even more benefits are expected to be uncovered upon completion of ongoing research.

Given the wide-ranging practice of holistic-based Eastern medicine, acceptance and use of CBD oils is not only a natural adjunct but also an enormous potential revenue generator for ChineseInvestors.com.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

Bollente Companies, Inc. (BOLC) is “One to Watch”

Bollente Companies, Inc. (OTCQB: BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under “trutankless”, a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente’s trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente’s trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system’s self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers.

For more information, visit the company’s website at www.BollenteCompanies.com

Let us hear your thoughts: Bollente Companies, Inc. Message Board

Greenkraft, Inc. (GKIT) Making Itself Available to the Entirety of the United States

March 28, 2017

Most vehicles across the United States are powered by either gasoline or diesel, but this is changing. Sales of cars, especially fleet vehicles, that operate on alternative fuels are growing, and, according to the U.S. Department Of Energy, natural gas now powers more than 150,000 vehicles across the country and over 15 million vehicles worldwide (http://dtn.fm/LF8Zg).

Because natural gas as a transportation fuel is widely distributed, domestically available, more cost efficient, and better for the environment, these new vehicles are expected to become increasingly popular for the foreseeable future, and, thanks to Greenkraft, Inc. (OTCQB: GKIT), they will soon be making their way across the U.S.

Greenkraft, a company that manufactures and markets alternative fuel systems to convert petrol-based vehicles and engines to function on natural gas and propane fuels, offers a variety of trucks and engines to suit various modern-day business needs. In fact, all of its products are built to suit companies in the food, electric, construction, and landscaping markets, among others.

Greenkraft prides itself on offering fuel efficient trucks that not only save businesses money, but are also better for the environment. These vehicles meet EPA and CARB emission standards and use only alternative fuels for power. To top it off, the company works closely with the government to encourage businesses to switch to more eco-friendly automobiles through tax incentives and rebates.

Most recently, Greenkraft announced that it will be launching a widespread national marketing campaign to include printed advertisements, trade shows, and targeted campaigns that will showcase its trucks and engines to the majority of the U.S. market. In addition to bringing in new customers, GKIT wants to educate companies about the positive environmental impact they could have by changing their transportation methods.

A month prior to this press release, the company announced that, due to increased demand for its products, it will be expanding to a bigger factory in 2017 and introduce new, larger-sized trucks in weights of 26,000 and 33,000 pounds, respectively. The combination of this new nationwide marketing campaign and its plans to expand to a bigger factory will enable GKIT to meet customer needs while having a serious positive impact on the environment.

For more information, visit www.GreenkraftInc.com

eXp World Holdings, Inc. (EXPI) Keeps Salespeople Satisfied and Selling

The sales profession is known for sales cycle stress, pressures to meet quotas and the debilitating psychological impact of constant rejection. Combined, these factors are known contributors to the sales industry’s exceptionally high turnover rates and lost productivity. The satisfaction level of salespeople may not seem to correlate directly with business objectives, but it substantially impacts an organization’s bottom line. Happy sales people are consistently more resourceful and productive. Sales can obviously be a tough job, with the daily grind of prospecting and repeated rejection. Even top producers can be pulled down by deals that linger but never seem to go through.

Research has proven that happiness is contagious, especially in sales. When salespeople truly enjoys their environment and what they’re doing, it leads to a more natural selling proposition and, ultimately, more success. They convert more leads and are generally more successful, because prospects are engaged and gravitate toward them. Happy salespeople are less stressed, undeterred by rejection, and consistently more productive.

More money can help enhance a sales person’s happiness, but more money alone does not directly equate to more happiness. More money helps, but well-researched psychological principles show that top salespeople want more. These principles show that sales producers are motivated by new challenges and responsibilities. They also want to continue to learn and hone their skills, an essential element of what makes them successful. More than most people, top sales performers need appreciation and recognition for their achievements, and they produce more in an environment that promotes relationships and provides meaning.

Few industries are more sales driven than residential real estate. Success is contingent upon attracting and keeping productive sales agents. Adding agents, reducing turn over, and increasing sales productivity makes or breaks agencies. eXp World Holdings, Inc. (OTCQB: EXPI) is changing the paradigm of real estate sales by using an advanced-technology online system to provide the tools, motivation, and support needed to attract and keep agents. eXp World Holdings is the publicly-traded holding company of eXp Realty, an agent-owned cloud-based residential brokerage. The company nearly tripled its agent count last year, with over 1,500 new real estate professionals joining eXp Realty in 2016. The dramatic increase in agents and revenues reflects the environment built by the company’s unique business model. eXp Realty believes the greatest asset of any real estate brokerage is the team of agents and brokers who create the revenues of the company.

By eliminating the high cost of brick and mortar locations, the company offers among the highest payouts in the industry. Agents and brokers receive exceptional support and continued education through eXp Realty’s innovative 24/7 cloud-based system of collaborative tools and training. Its 3-D, fully-immersive, cloud office environment also promotes agent socialization, relationship enhancement, and agent recognition. Proof of eXp’s pioneering approach is borne out not only by the striking increase in agents last year, but also by the myriad of positive online reviews posted by agents.

By surreptitiously abetting sales agent happiness with tangible and intangible support systems, eXp is poised to not only continue adding legions of agents, but also to dramatically exceed revenue expectations.

For more information, visit the company’s website at www.eXpWorldHoldings.com

Let us hear your thoughts: eXp World Holdings, Inc. Message Board

India Globalization Capital, Inc. (NYSE: IGC) Aims to Become a Leading Provider of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products. This is a transition away from its earlier short-term strategy, including the sale of electronics and development of a hotel site in Malaysia. To this end, the company has jettisoned its electronics business. IGC is now fully focused on building a portfolio of patents and starting clinical and pre-clinical trials for a series of pain-reducing and other cannabis-based therapies. These therapies are designed to treat neuropathic pain, seizures, Parkinson’s, anorexia/cachexia, Alzheimer’s, and PTSD.

Ram Mukunda, CEO of the company, indicated that IGC’s 2017 goals are focused on its progression toward commencement of clinical trials for these combination therapies. The Journal of Pain, in September 2012, reported that between $560 billion and $635 billion is spent annually in the U.S. for pain management, making it a significant part of the American health care system. In response, IGC has developed a series of drugs for pain and other disorders, including IGC-501 for neuropathic pain, IGC-502 for the treatment of seizures, and IGC-504 and IGC-506 for eating disorders and cachexia.

The company recently filed for issuance of a provisional patent for IGC-506, a combination of cannabis-based extracts and other compounds. It should be noted that a provisional patent does not assure the issuance of a patent in the future.

Mukunda explained that IGC is starting a review of international medical sites as the company seeks preclinical and clinical trials of its patent portfolio. He described the marketplace that IGC is entering as large, indicating that trials, patents and seeking approval from the U.S. Food & Drug Administration is seen as cost-effective.

For more information, visit the company’s website at www.IGCinc.us

Let us hear your thoughts: India Globalization Capital, Inc. Message Board

Heat Biologics (NASDAQ: HTBX) at the Vanguard of a Paradigm Shift in Cancer Treatment

March 24, 2017

The human body is elegantly designed to heal itself, utilizing the immune system as its defense against various pathogens. Triggered by immune response signals, the immune system attacks and kills organisms and substances that invade body systems and cause disease. However, the immune system sometimes needs help in identifying and killing some invaders.

Cancer presents a complex and perplexing problem for effective immune system response, because it finds ways to hide from the immune system or block the immune system’s ability to battle against the disease. An important part of the immune system is its ability to differentiate between normal cells in the body and invaders. This differentiation allows the immune system to attack the invading cells while leaving normal cells alone. To achieve this, the immune system uses molecules on certain immune cells that need to be activated or inactivated to trigger an immune response. However, cancer cells can sometimes use these checkpoints to deceive the immune system and avoid being attacked. Newly developed drugs, known as checkpoint inhibitors, have shown some success in cancer treatments. However, a combination of checkpoint inhibitors and specific T cell-stimulating therapeutic vaccines indicates a much higher degree of efficacy.

Heat Biologics (NASDAQ: HTBX) is at the vanguard of this shift in cancer treatments, developing novel therapeutic vaccines to activate the immune system against a wide range of cancers. When antigens enter the body, they stimulate the immune system to produce antibodies in response to these foreign substances. Heat Biologics exploits this natural process to elicit a powerful immune response against the disease target. The company’s therapeutic vaccines are based on heat shock protein gp-96, a protein that activates the immune system when cells die. This protein is attached to the cell by what’s called a KDEL leash. Heat Biologic’s vaccines remove this leash and cause cells to continuously secrete gp96 and its chaperoned antigens to activate the immune system.

Heat Biologics recently announced the latest results of its ongoing phase 2 clinical trial in combination with Bristol-Myers Squibb’s checkpoint inhibitor. Researchers reported a strong correlation between T cell activation, tumor reductions, and increased overall survival in the patients evaluated. Patients with a sustained immune response also exhibited substantial tumor reductions. It appears the combination of Heat Biologics’ vaccine and checkpoint inhibitors may become an attractive therapeutic approach treating cancers.

For more information, please visit www.HeatBio.com

Archives

Select A Month
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search

    Categories

    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • AlphaTrade.com APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • Barchart.com (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • BizRocket.com Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • Bollente Companies, Inc. BOLC (2)
  • BoonMarket.com (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises, Inc. CDII (29)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • Chineseinvestors.com, Inc. CIIX (17)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • Connect-A-Jet.com CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (73)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • EFoodSafety.com Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz Inc. EPAZ (22)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Etelcharge.com Inc. ETLC (3)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (81)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  • Fund.com, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • GotStocks.net (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • GreeneStone Healthcare Corp. GRST (5)
  • Greenstone Holdings Inc. GSHN (2)
  • GREM USA GRMU (2)
  • Grey Cloak Tech, Inc. GRCK (2)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital, Inc. IGC (11)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • InMed Pharmaceuticals, Inc. IMLFF (5)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Loans4Less.com Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • MGX Minerals, Inc. MGXMF (4)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (47)
  • Money4Gold Holdings Inc. MFGD (3)
  • MortgageBrokers.com Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • MyStaru.com Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (23)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One Step Vending Corp. KOSK (2)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,350)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORHub, Inc. ORHB (5)
  • OTCPicks.com (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Player's Network, Inc. PNTV (2)
  • Players Network PNTV (4)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProBility Media Corp. PBYA (7)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,170)
  • QualityStocks Video Charts (286)
  • QualityStocks.net Market Basics (6)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (65)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • Smallcaps.us (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (3)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,873)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune, Inc. TPIV (15)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.